Effect of Cordia myxa syrup on acute diarrhea

Survey the Cordia myxa syrup effect in reducing the severity and duration of diarrhea in hospitalized children due to gastroenteritis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200202046341N2

Enrollment

140

Registered

2024-04-21

Start date

2024-02-20

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroentritis. Other specified noninfective gastroenteritis and colitis

Interventions

Intervention 1: Control group: Placebo was administered three times a day (once every 8 hours). Intervention 2: Intervention group: Cordia myxa syrup 3% in the amount of 3 mg per kilogram of body weig

Eligibility

Sex/Gender

All

Age

12 Months to 96 Months

Inclusion criteria

Inclusion criteria: Children from 12 months to 96 months Suffering from acute gastroenteritis Not receiving drug treatment before entering the study

Exclusion criteria

Exclusion criteria: Patients with severe dehydration Presence of abnormal findings in stool test such as blood Existence of surgical problem such as acute abdominal surgery Suffering from another disease or receiving another drug during the study Non-adherence to the treatment protocol or leaving the treatment before complete recovery Frequent vomiting and drug intolerance Patient withdrawal from participating in the study

Design outcomes

Primary

Measure	Time frame
Frequency of diarrhea. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Severity of diarrhea. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Stool consistancy. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Stool volume. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Percentage of recovered people. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.	—

Measure

Time frame

Frequency of diarrhea. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Severity of diarrhea. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Stool consistancy. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Stool volume. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.;Percentage of recovered people. Timepoint: the first, second, third, seventh day and also at the end of the study (one week). Method of measurement: Questionnaire made by the researcher.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMana Hafezi

Ahvaz University of Medical Sciences

fatemekhazaali80@gmail.com+98 61 3444 0903

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026